Transportation innovation to aid Parkinson disease trial recruitment.

Transportation innovation to aid Parkinson disease trial recruitment.

Publication date: Dec 01, 2019

Among the barriers to participation in clinical trials, transportation to and from study sites may be a prominent issue. Patients with Parkinson’s disease have unique circumstances that add to the barriers including dementia, loss of driving ability, timing of medications, impact of reduced mobility, and bowel and bladder concerns. We sought to alleviate some of the burden of transportation by setting up pre-arranged rides through a third-party ride sharing service. This pilot project was established to assess feasibility and to explore the possibility that reducing the transportation burden may enhance participation in studies. One out of three academic sites was successful in setting up this service, and surveyed participants on the impact of this service. In general, study participants who opted into the ride-sharing service felt it made the process easier and less stressful. Most participants agreed that they are more likely to participate in another study if transportation was provided. This short-term pilot intervention suggests that participants were satisfied with a ride sharing service to help with their medical transportation needs, but larger studies that include data collection about retention are needed.

Open Access PDF

Frank, S., Berk, S., Hernandez, L., Hogarth, P., Shill, H.A., Siddiqi, B., and Simon, D.K. Transportation innovation to aid Parkinson disease trial recruitment. 23127. 2019 Contemp Clin Trials Commun (16):

Concepts Keywords
Bladder Design of experiments
Bowel Clinical trial
Clinical Trials Clinical research
Dementia Carpool
Parkinson Sustainable transport
Ride Sharing Clinical pharmacology
Pharmaceutical industry
Health
Transport
Dementia
Transportation burden
Transportation innovation aid
Burden transportation
Transportation needs

Semantics

Type Source Name
disease MESH Parkinson disease
pathway KEGG Parkinson disease
disease MESH dementia

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *